EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World

Bruno Fattizzo iD, Carmelo Gurnari iD, Sabrina Giammarco, Antony Ricchiuti, Hussein Awada iD, Marta Bortolotti iD, Nicole Galli iD, Giacinto Luca Pedone iD, Francesco Versino, Dario Consonni, Roochi Trikha, Shreyans Gandhi und 4 weitere

American Journal of Hematology · 2025

DOI: 10.1002/ajh.27611 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Bruno Fattizzo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Anemia, Aplastic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Current Research Grant, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We retrospectively analyzed a large international cohort of 1113 patients with aplastic anemia to evaluate treatment choice and outcome in elderly patients as compared with a younger population. Overall, 319 (29%) patients were > 60 years old at diagnosis (60–64 years ( n = 85), 106 65–69 years ( n = 106), and 128 > 70 years ( n = 128)). Elderly patients showed a more severe thrombocytopenia at onset and a significantly lower overall response (complete plus partial) to first‐line therapy at 6 months as compared to younger patients (47% vs. 65%, p < 0.0001), irrespective of treatment modality (ATG or CyA combinations, eltrombopag, or androgens); 27 (8%) received transplant as second line therapy and 11 (41%) died, mainly due to transplant complications. The rate of evolution to MDS was greater in elderly patients (12% vs. 7% in younger AA, p = 0.002), whilst the rate of evolution to AML was similar (1.8 vs. 1.3%). By multivariable analysis, older age remained the main factor associated with mortality [HR 1.64 (95% CI 1.5–1.7), p < 0.001], followed by disease severity by Camitta classification [HR 2.24 (95% CI 1.6–3.1) for severe AA; HR 3.8 (95% CI 2.4–6) for very severe AA], and male gender [1.45 (95% CI 1.1–1.8), p < 0.001]. In this large study, elderly AA was associated with inferior outcome even in the TPO‐RA era, highlighting the need for further optimization of clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAge FactorsAntilymphocyte SerumBenzoatesCyclophosphamideCyclosporineHematopoietic Stem Cell TransplantationHydrazinesLeukemia, Myeloid, AcuteMyelodysplastic SyndromesPyrazolesRetrospective StudiesThrombocytopeniaTreatment Outcome

Stichwörter der Autor:innen

anti‐thymocyte globulinaplastic anemiacyclosporineelderlyeltrombopag

Substanzen

Antilymphocyte SerumBenzoatesCyclophosphamideCyclosporineeltrombopagHydrazinesPyrazoles

Autor:innen und Institutionen

  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Fondazione Policlinico Universitario A. Gemelli-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Hematology Unit, King's College Hospital, London, UK.

ORCID-Profile: Bruno Fattizzo, Carmelo Gurnari, Hussein Awada, Marta Bortolotti, Nicole Galli, Giacinto Luca Pedone, Austin Kulasekararaj, Wilma Barcellini

Förderung

  • Italian Ministry of Health, Current Research Grant
  • Ministero della Salute

Zitieren

APA

Fattizzo, B., Gurnari, C., Giammarco, S., Ricchiuti, A., Awada, H., Bortolotti, M., Galli, N., Pedone, G. L., Versino, F., Consonni, D., Trikha, R., Gandhi, S., Sica, S., Maciejewski, J. P., Kulasekararaj, A., & Barcellini, W. (2025). Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World. American Journal of Hematology. https://doi.org/10.1002/ajh.27611

Vancouver

Fattizzo B, Gurnari C, Giammarco S, Ricchiuti A, Awada H, Bortolotti M, et al. Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World. American Journal of Hematology. 2025. doi:10.1002/ajh.27611

BibTeX
@article{Fattizzo2025,
  author = {Fattizzo, Bruno and Gurnari, Carmelo and Giammarco, Sabrina and Ricchiuti, Antony and Awada, Hussein and Bortolotti, Marta and Galli, Nicole and Pedone, Giacinto Luca and Versino, Francesco and Consonni, Dario and Trikha, Roochi and Gandhi, Shreyans and Sica, Simona and Maciejewski, Jaroslaw P and Kulasekararaj, Austin and Barcellini, Wilma},
  title = {Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World},
  journal = {American Journal of Hematology},
  year = {2025},
  doi = {10.1002/ajh.27611}
}
Kostenlos starten →